OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques.
Wittwer
C T
CT
Department of Pathology, University of Utah Medical Center, Salt Lake City 84132.
Bristow
M R
MR
Gilbert
E M
EM
Renlund
D G
DG
O'Connell
J B
JB
DeWitt
C W
CW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000937:Antigen-Antibody Reactions; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods*; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents